An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.
These findings are detailed in the new edition of Nature.
During 2014, the outbreak of the West African Makona strain of Ebola Zaire virus killed nearly 10,000 and caused worldwide concern. With increasing population growth in West Africa, the frequency of contact between humans and natural Ebola virus hosts such as bats will likely rise, potentially leading to more catastrophic outbreaks.
Many vaccine approaches have shown promise in being able to protect nonhuman primates against Ebola Zaire. In response to the Ebola Zaire outbreak, several of these vaccines have been fast tracked for human use.
One of those vaccines, developed by UTMB and Profectus, has been undergoing testing in the Galveston National Laboratory, the only fully operational Biosafety Level 4 laboratory on an academic campus in the U.S.
“These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks,” said Thomas Geisbert, UTMB professor of microbiology and immunology. “We are excited at the possibility of helping develop a way to stop this deadly disease. We have a lot of more work to accomplish but it’s important to note that this is a big step.”
The research team developed a vaccine effective against Ebola Zaire with a single dose in a nonhuman primate model. This new vaccine employs a virus not harmful to humans called vesicular stomatitis virus that had a part of the Ebola virus inserted into it. This “Trojan horse” vaccine safely triggered an immune response against Ebola Zaire.
To address any possible safety concerns associated with this vaccine, the team developed two next generation candidate vaccines that contain further weakened forms of the vaccine. Both of these vaccines produced an approximately ten-fold lower level of virus in the blood compared to the first generation vaccine.
“It was not known whether any of these vaccines could provide protection against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea,” said John Eldridge, Chief Scientific Officer-Vaccines at Profectus Biosciences, Inc. “Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virus.”
The Latest on: Ebola
via Google News
The Latest on: Ebola
- ‘Apocalyptic’ Ebola and childhood pandemic tragedy: The untold heartbreak that haunts Qld CHOon January 21, 2022 at 4:05 pm
If Dr John Gerrard can cobble together a spare hour or two, there’s a storage shed in suburban Gold Coast where he likes to go. He rolls up the garage door, enters his man cave and surrenders to a ...
- The family tragedy that drives Queensland's no-nonsense top doctor in the fight against Covid - after he helped battle 'apocalyptic' Ebola outbreak in Africaon January 21, 2022 at 9:36 am
Queensland's new Chief Health Officer, Dr John Gerrard, has revealed his long standing history with infectious diseases from his brother's death in 1968 from influenza to his work with ebola in Africa ...
- COVID Shows It’s Time to End the Pharmaceutical Industryon January 21, 2022 at 5:57 am
Even at this late date, now is a good time to start. As with COVID testing, thousands of newly hired community health workers are needed to hit the streets and back roads to convince people that ...
- Sherif Ramzy Zakion January 20, 2022 at 4:04 pm
Leading US infectious disease pathologist. He was born in Alexandria, Egypt, on Nov 24, 1955 and died after a fall in Atlanta, GA, USA, on Nov 21, 2021 aged 65 years.
- AFCON 2021: Sierra Leone's 'nearly men' enjoying their momenton January 20, 2022 at 1:14 am
For the first time since 1996, Sierra Leone are back competing in an African Cup of Nations. The Leone Stars have upset two tournament favorites in a remarkable comeback story.
- 'Ebola for pigs' among projects in $5M of research spendingon January 19, 2022 at 3:15 pm
Suresh Tikoo’s newest research project is to study a virus with a nearly 100 per cent fatality rate. It has no vaccine. It can kill quickly, sometimes within 24 hours. If it arrives it in Canada, it ...
- Potentially deadly rumors suggest COVID vaccines contain Ebolaon January 19, 2022 at 12:22 am
One twitter user ‘@onthislasthill’ tweeted, “Rumors of latent Marburg and Ebola cells are said to have been found in the COV vaxxs. Pay attention.” Official reports said there were a few positive ...
- Bill & Melinda Gates Foundation and Wellcome Pledge US$300 Million to CEPI for COVID-19 Pandemic Response and to Accelerate Epidemic Preparednesson January 18, 2022 at 3:01 pm
The foundations call on world leaders to support the Coalition for Epidemic Preparedness Innovations (CEPI) to help end the COVID-19 crisis, prepare for future pandemics, and address epidemic threats.
- How Obama's Handling Of Ebola Compares With Trump's Handling Of Coronaviruson January 18, 2022 at 6:29 am
Though COVID-19 has caused a massive disruption to the United States unlike any epidemic in recent history, Trump’s handling of the virus has been contrasted with former President Barack Obama’s ...
- Border Agents Seize Dangerous 'Bushmeat' Including Bats & Monkeys Carrying Ebolaon January 12, 2022 at 12:52 pm
Saint Paul International Airport (MSP), U.S. Customs and Border Protection (CBP) officers have identified a trend that could have deadly effects and lead to another outbreak of disease. The culprit is ...
via Bing News